skip to content

Interim Results

UDG Healthcare lifts H1 pretax profit

23 May 2017 07:31

UDG Healthcare has lifted its H1 pretax profit to $40.9m, from $35.4m, as it upped its EPS guidance for the FY.

Revenue was $578.9m, up from $537.9m. Diluted earnings per share (EPS) from continuing operations increased by 19% (29% on a constant currency basis), aided by acquisitions and other timing benefits during the half.

"The first half of 2017 has been another very progressive period for UDG Healthcare, with strong growth delivered and continued progress made in pursuit of the Group's strategic objectives," said CEO Brendan McAtamney.

"The continuing Group's earnings per share increased by 19% (29% on a constant currency basis), driven by continued momentum in underlying profit growth and a strong performance by our recent acquisition, STEM.

"The Group is increasing its guidance for constant currency diluted EPS for the year to 30 September 2017 by 2% to a range of between 15% and 18% ahead of last year."

Story provided by

Related Company: UDG

Info Point:

To buy or sell shares call our Dealing Room on 0113 243 6941.

Too much jargon? Our glossary will help make sense of things.

Find out more about our Share Dealing Services.

Client Area Access

» Secure Login

» Not registered yet?


Branch Finder

Redmayne-Bentley have High Street branches throughout the UK. Find your nearest branch.